Market Overview:
The global apheresis market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in apheresis devices. Based on type, the centrifugation segment is expected to account for the largest share of the global apheresis market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. Centrifugation-based apheresis devices are widely used for blood component separation and are considered as gold standard devices for therapeutic plasma exchange (TPE) and plateletpheresis procedures. Based on application, renal diseases accounted for the largest share of the global apheresis market in 2017.
Product Definition:
Apheresis is a medical procedure in which blood is drawn from a patient, the plasma and platelets are separated from the red blood cells, and the desired component is returned to the patient.
Centrifugation:
Centrifugation is a process of separating the blood components by creating high-speed rotating force. The centrifugal force separates the blood cells from the plasma using spinning containers called centrifuge or separator. Centrifuges are available in different sizes, shapes and can be customized according to need.
The major applications of centrifugation include separation of white cells from red cells in dialysis, leukemia treatment,.
Membrane Filtration:
Membrane filtration is a process to separate particles based on their size, by using a semi-permeable membrane. The most common application of membrane filtration is in the production of Apheresis products. In this process, plasma is separated from blood cells by using an ultrafiltration membrane with a pore size of 0.2 microns or less.
The global apheresis market was valued at USD 6,500 million in 2015.
Application Insights:
The application segment is segregated into renal diseases, neurology, cancer, hematology autoimmune diseases. Renal disease held the largest market share in 2017 owing to increasing prevalence of chronic kidney disease (CKD) and rising demand for effective treatment options. According to a study published by the National Center for Biotechnology Information (NCBI) in 2018, it was estimated that more than 300 million people across the globe have CKD.
Apheresis treatments are used as an effective treatment option for patients with CKD due to low blood flow through kidneys or reduced functioning of kidneys due to other causes such as diabetes or hypertension. The rising prevalence of autoimmune diseases such as lupus erythematosus and rheumatoid arthritis also boosts product demand globally. Moreover, growing number of approvals by regulatory authorities for new apheresis products in various regions including North America and Europe will further boost industry growth over the forecast period.
Regional Analysis:
North America dominated the global apheresis market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing R&D activities are some of the major factors responsible for North America’s dominance. In addition, growing target population base with high unmet medical needs coupled with rising prevalence of chronic diseases is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving healthcare infrastructure and expansion of private hospitals & nursing homes along with an increase in government initiatives for improving public health system & facilities which would subsequently boost demand for blood donation leading to increased revenue generation from apheresis products as well as other plasma-derived products such as clotting factors (fibrinogen), immunoglobulin (IgG) therapies, vaccines etc.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases such as cancer, autoimmune disorders, and blood disorders is increasing globally. This is leading to an increase in the demand for apheresis procedures as they are used for the treatment of these conditions.
- Technological advancements: Apheresis technology is evolving rapidly with new devices and procedures being developed constantly. This is resulting in increased efficiency and safety of apheresis treatments, which is driving their adoption.
- Growing awareness about apheresis: There has been a growing awareness about the benefits of apheresis among both patients and healthcare professionals in recent years. This has led to an increase in its use for various indications across the globe.
Scope Of The Report
Report Attributes
Report Details
Report Title
Apheresis Market Research Report
By Type
Centrifugation, Membrane Filtration
By Application
Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases
By Companies
Asahi Kasei Medical, Terumo Corporation, Haemonetics Corporation, Fresenius Kabi, Cerus Corporation, B. Braun Melsungen, Kawasumi Laboratories, NIKKISO, Therakos, Medica S.p.A, Asahi Kasei Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
218
Number of Tables & Figures
153
Customization Available
Yes, the report can be customized as per your need.
Global Apheresis Market Report Segments:
The global Apheresis market is segmented on the basis of:
Types
Centrifugation, Membrane Filtration
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Asahi Kasei Medical
- Terumo Corporation
- Haemonetics Corporation
- Fresenius Kabi
- Cerus Corporation
- B. Braun Melsungen
- Kawasumi Laboratories
- NIKKISO
- Therakos
- Medica S.p.A
- Asahi Kasei Medical
Highlights of The Apheresis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Centrifugation
- Membrane Filtration
- By Application:
- Renal Diseases
- Neurology
- Cancer
- Hematology
- Autoimmune Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Apheresis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Apheresis is a medical procedure that uses a machine to remove blood from the body.
Some of the major companies in the apheresis market are Asahi Kasei Medical, Terumo Corporation, Haemonetics Corporation, Fresenius Kabi, Cerus Corporation, B. Braun Melsungen, Kawasumi Laboratories, NIKKISO, Therakos, Medica S.p.A, Asahi Kasei Medical.
The apheresis market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Apheresis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Apheresis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Apheresis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Apheresis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Apheresis Market Size & Forecast, 2020-2028
4.5.1 Apheresis Market Size and Y-o-Y Growth
4.5.2 Apheresis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Centrifugation
5.2.2 Membrane Filtration
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Renal Diseases
6.2.2 Neurology
6.2.3 Cancer
6.2.4 Hematology
6.2.5 Autoimmune Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Apheresis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Apheresis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Centrifugation
9.6.2 Membrane Filtration
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Renal Diseases
9.10.2 Neurology
9.10.3 Cancer
9.10.4 Hematology
9.10.5 Autoimmune Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Centrifugation
10.6.2 Membrane Filtration
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Renal Diseases
10.10.2 Neurology
10.10.3 Cancer
10.10.4 Hematology
10.10.5 Autoimmune Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Centrifugation
11.6.2 Membrane Filtration
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Renal Diseases
11.10.2 Neurology
11.10.3 Cancer
11.10.4 Hematology
11.10.5 Autoimmune Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Centrifugation
12.6.2 Membrane Filtration
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Renal Diseases
12.10.2 Neurology
12.10.3 Cancer
12.10.4 Hematology
12.10.5 Autoimmune Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Centrifugation
13.6.2 Membrane Filtration
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Renal Diseases
13.10.2 Neurology
13.10.3 Cancer
13.10.4 Hematology
13.10.5 Autoimmune Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Apheresis Market: Competitive Dashboard
14.2 Global Apheresis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Asahi Kasei Medical
14.3.2 Terumo Corporation
14.3.3 Haemonetics Corporation
14.3.4 Fresenius Kabi
14.3.5 Cerus Corporation
14.3.6 B. Braun Melsungen
14.3.7 Kawasumi Laboratories
14.3.8 NIKKISO
14.3.9 Therakos
14.3.10 Medica S.p.A
14.3.11 Asahi Kasei Medical
